Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

313 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Toward a Universal Readout for 18F-Labeled Amyloid Tracers: The CAPTAINs Study.
Bischof GN, Bartenstein P, Barthel H, van Berckel B, Doré V, van Eimeren T, Foster N, Hammes J, Lammertsma AA, Minoshima S, Rowe C, Sabri O, Seibyl J, Van Laere K, Vandenberghe R, Villemagne V, Yakushev I, Drzezga A. Bischof GN, et al. Among authors: seibyl j. J Nucl Med. 2021 Jul 1;62(7):999-1005. doi: 10.2967/jnumed.120.250290. Epub 2021 Mar 12. J Nucl Med. 2021. PMID: 33712532 Free article.
Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study.
Barthel H, Gertz HJ, Dresel S, Peters O, Bartenstein P, Buerger K, Hiemeyer F, Wittemer-Rump SM, Seibyl J, Reininger C, Sabri O; Florbetaben Study Group. Barthel H, et al. Among authors: seibyl j. Lancet Neurol. 2011 May;10(5):424-35. doi: 10.1016/S1474-4422(11)70077-1. Epub 2011 Apr 8. Lancet Neurol. 2011. PMID: 21481640 Clinical Trial.
SNM practice guideline for dopamine transporter imaging with 123I-ioflupane SPECT 1.0.
Djang DS, Janssen MJ, Bohnen N, Booij J, Henderson TA, Herholz K, Minoshima S, Rowe CC, Sabri O, Seibyl J, Van Berckel BN, Wanner M. Djang DS, et al. Among authors: seibyl j. J Nucl Med. 2012 Jan;53(1):154-63. doi: 10.2967/jnumed.111.100784. Epub 2011 Dec 8. J Nucl Med. 2012. PMID: 22159160 Free article. No abstract available.
Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer's disease and cognitively normal subjects.
Joshi AD, Pontecorvo MJ, Clark CM, Carpenter AP, Jennings DL, Sadowsky CH, Adler LP, Kovnat KD, Seibyl JP, Arora A, Saha K, Burns JD, Lowrey MJ, Mintun MA, Skovronsky DM; Florbetapir F 18 Study Investigators. Joshi AD, et al. Among authors: seibyl jp. J Nucl Med. 2012 Mar;53(3):378-84. doi: 10.2967/jnumed.111.090340. Epub 2012 Feb 13. J Nucl Med. 2012. PMID: 22331215 Free article.
Kinetic modeling, test-retest, and dosimetry of 123I-MNI-420 in humans.
Tavares AA, Batis JC, Papin C, Jennings D, Alagille D, Russell DS, Vala C, Lee H, Baldwin RM, Zubal IG, Marek KL, Seibyl JP, Barret O, Tamagnan GD. Tavares AA, et al. J Nucl Med. 2013 Oct;54(10):1760-7. doi: 10.2967/jnumed.113.119933. Epub 2013 Aug 22. J Nucl Med. 2013. PMID: 23970369 Free article. Clinical Trial.
Aβ imaging with 18F-florbetaben in prodromal Alzheimer's disease: a prospective outcome study.
Ong KT, Villemagne VL, Bahar-Fuchs A, Lamb F, Langdon N, Catafau AM, Stephens AW, Seibyl J, Dinkelborg LM, Reininger CB, Putz B, Rohde B, Masters CL, Rowe CC. Ong KT, et al. Among authors: seibyl j. J Neurol Neurosurg Psychiatry. 2015 Apr;86(4):431-6. doi: 10.1136/jnnp-2014-308094. Epub 2014 Jun 26. J Neurol Neurosurg Psychiatry. 2015. PMID: 24970906 Clinical Trial.
313 results